Welch & Forbes LLC Decreases Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Welch & Forbes LLC decreased its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.6% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 9,905 shares of the medical equipment provider’s stock after selling 55 shares during the period. Welch & Forbes LLC’s holdings in Intuitive Surgical were worth $3,342,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Baystate Wealth Management LLC grew its stake in Intuitive Surgical by 150.0% in the 4th quarter. Baystate Wealth Management LLC now owns 75 shares of the medical equipment provider’s stock valued at $25,000 after buying an additional 45 shares during the last quarter. MCF Advisors LLC increased its stake in Intuitive Surgical by 108.1% during the fourth quarter. MCF Advisors LLC now owns 77 shares of the medical equipment provider’s stock valued at $26,000 after acquiring an additional 40 shares during the period. Atticus Wealth Management LLC raised its holdings in Intuitive Surgical by 85.4% in the 4th quarter. Atticus Wealth Management LLC now owns 89 shares of the medical equipment provider’s stock valued at $30,000 after acquiring an additional 41 shares in the last quarter. MeadowBrook Investment Advisors LLC bought a new stake in shares of Intuitive Surgical in the 4th quarter worth approximately $30,000. Finally, OFI Invest Asset Management bought a new stake in shares of Intuitive Surgical during the third quarter valued at approximately $25,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Analysts Set New Price Targets

ISRG has been the topic of several analyst reports. Citigroup boosted their price target on shares of Intuitive Surgical from $428.00 to $462.00 and gave the company a “buy” rating in a report on Wednesday, April 3rd. Barclays increased their price target on shares of Intuitive Surgical from $385.00 to $430.00 and gave the stock an “overweight” rating in a research report on Thursday, January 25th. StockNews.com downgraded Intuitive Surgical from a “buy” rating to a “hold” rating in a report on Thursday, February 29th. Wells Fargo & Company increased their target price on Intuitive Surgical from $363.00 to $416.00 and gave the stock an “overweight” rating in a report on Friday, January 19th. Finally, Raymond James lifted their price objective on Intuitive Surgical from $372.00 to $435.00 and gave the company an “outperform” rating in a report on Thursday, January 25th. Five equities research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $396.17.

Insider Activity

In other news, President David J. Rosa sold 80,710 shares of the business’s stock in a transaction dated Wednesday, February 7th. The stock was sold at an average price of $389.28, for a total transaction of $31,418,788.80. Following the sale, the president now directly owns 163,399 shares in the company, valued at $63,607,962.72. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. In related news, Director Mark J. Rubash sold 1,709 shares of the business’s stock in a transaction on Friday, May 3rd. The shares were sold at an average price of $380.00, for a total value of $649,420.00. Following the transaction, the director now owns 16,051 shares in the company, valued at $6,099,380. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, President David J. Rosa sold 80,710 shares of the stock in a transaction that occurred on Wednesday, February 7th. The stock was sold at an average price of $389.28, for a total value of $31,418,788.80. Following the transaction, the president now owns 163,399 shares in the company, valued at $63,607,962.72. The disclosure for this sale can be found here. In the last ninety days, insiders sold 228,637 shares of company stock worth $88,483,248. Insiders own 0.80% of the company’s stock.

Intuitive Surgical Trading Up 1.5 %

NASDAQ ISRG traded up $5.60 during trading on Tuesday, reaching $388.65. The company’s stock had a trading volume of 932,774 shares, compared to its average volume of 1,608,281. The firm has a market capitalization of $137.86 billion, a price-to-earnings ratio of 70.15, a price-to-earnings-growth ratio of 4.93 and a beta of 1.39. The firm has a 50 day moving average price of $385.34 and a 200 day moving average price of $351.97. Intuitive Surgical, Inc. has a 12 month low of $254.85 and a 12 month high of $403.76.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Thursday, April 18th. The medical equipment provider reported $1.50 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.40 by $0.10. The company had revenue of $1.89 billion for the quarter, compared to analyst estimates of $1.87 billion. Intuitive Surgical had a net margin of 27.16% and a return on equity of 12.91%. The firm’s revenue was up 11.5% on a year-over-year basis. During the same period in the previous year, the firm posted $1.00 EPS. On average, equities analysts forecast that Intuitive Surgical, Inc. will post 4.8 EPS for the current fiscal year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.